Sanofi (SNY) is standing firm on $69/share as it launches its tender offer for Genzyme (GENZ),...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi (SNY) is standing firm on $69/share as it launches its tender offer for Genzyme (GENZ), but some analysts think the tough talk on no price hikes will ultimately give way. Even without a white knight to contend with, Sanofi may find raising its offer closer to $75/share is in its own interest.